R. Raul Rodriguez's most recent trade in Rigel Pharmaceuticals was a trade of 30,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 26,250 | 26,250 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 04 Feb 2025 | 4,952 | 243,854 (0%) | 0% | 20.9 | 103,601 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 04 Feb 2025 | 4,400 | 239,454 (0%) | 0% | 21.9 | 96,474 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 63,400 | 63,400 | - | - | Employee Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 42,300 | 248,806 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.40 per share. | 24 Jan 2025 | 45,000 | 249,662 (0%) | 0% | 21.4 | 963,000 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.40 per share. | 24 Jan 2025 | 45,000 | 250,584 (0%) | 0% | 21.4 | 963,000 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 45,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 45,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.17 per share. | 24 Jan 2025 | 44,078 | 205,584 (0%) | 0% | 22.2 | 977,209 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.17 per share. | 24 Jan 2025 | 44,078 | 206,506 (0%) | 0% | 22.2 | 977,209 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Aug 2024 | 32,500 | 32,500 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 02 Feb 2024 | 30,545 | 2,036,629 (1%) | 0% | 1.1 | 34,821 | Common Stock |
| Rigel Pharmaceuticals | R. Raul Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 02 Feb 2024 | 22,349 | 2,067,174 (1%) | 0% | 1.1 | 25,261 | Common Stock |
| Rigel Pharmaceuticals | Rodriguez R. Raul | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | R. Raul Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 400,000 | 2,089,523 (1%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 300,000 | 1,701,053 (1%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 200,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Sale of securities on an exchange or to another person at price $ 1.75 per share. | 26 Jan 2023 | 20,340 | 1,680,713 (0%) | 0% | 1.8 | 35,595 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 09 Jun 2022 | 1,000,000 | 1,391,776 (0%) | 0% | 0.7 | 688,400 | Common Stock |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 200,000 | 391,776 (0%) | 0% | 0 | Common Stock | |
| Rigel Pharmaceuticals | Raul R. Rodriguez | Director, CEO, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 525,000 | 525,000 | - | - | Stock Option(right to buy) |